This paper describes the male germ cell phenotype of mice lacking the bromodomain containing protein BRDT or mice expressing variants of BRDT with a C-terminal tag or deletion of the first bromodomain. The authors convincingly show that BRDT is required for normal meiosis and differentiation of post-meiotic cells and that globally it activates a series of pre-meiotic and postmeiotic genes and represses spermatogonial genes mostly in an indirect fashion. These data are backed up by transcriptomics, and ChIP-seq data as well as analysis of mice expressing BD1-deleted or tagged BRDT. While this analysis is well performed and convincing, the paper at present lacks mechanistic insight into the molecular function of BRDT and could be strengthened by some additional experiments. 1). Page 8 a detailed description of the BRDT ChIP-seq data is required. The number of reads, the number of peaks, the global distribution of peaks over the genome should be indicated. Are they located only at promoters or is there enrichment of peaks at other genomic locations ?
2). The authors show that BRDT interacts with PTEFB components CDK9 and Cyclin T1. Can the authors show that this is the case on promoters. ChIP-seq could indicate if there is a global colocalisation of BRDT and PTEFB at target promoters and interestingly whether BRDT binding and PTEFB binding are coordinately increased and lost at the meiotic and post-meiotic promoters. Also the authors state that BRDT is acting as an activator of post-meiotic expressed genes and in some way bookmarks them as many already show significant BRDT occupancy in pre-meiotic cells. Is PTEFB-present at these promoters also in pre-meiotic cells ? One mechanism of action of BRD4 is to stimulate transcription elongation at promoters where there is a 'paused' Pol II. It is possible therefore that Pol II is recruited, but paused at a set of post-meiotic genes in pre-meiotic cells and the BRDT is required to promote the transition to the elongation phase in the round spermatids. The other possibility (that is another way of expressing almost the same idea) is that a set of post-meiotic genes are bookmarked by H4K5ac in pre-meiotic cells that facilitates BRDT recruitment and their activation in round spermatids. Both of these ideas can be tested by ChIP (or ChIP-seq) experiments asking if H4K5ac, Pol II and/or PTEFB are present on BRDT-occupied post-meiotic gene promoters in pre-meiotic cells. The authors have the material to address these questions and this type of data would provide mechanistic insight into BRDT function and considerably strengthen the paper.
Referee #3
The manuscript by Gaucher et al. examined the function of Brdt in spermatogenesis. The authors first examined the expression of Brdt in germ cells during the first wave spermatogenesis and in adults, and found that it initiates specific expression in meiotic spermatocytes and continues to be expressed thereafter. The authors then generated Brdt knockout mice, which exhibited complete loss of post-meiotic germ cells, i.e., round spermatids. The authors showed that although Brdt knockout spermatocytes reach the pachytene stage, they appeared to fail to undergo subsequent first meiotic division. The authors then explored the genes affected in the absence of Brdt by comparing the genes expressed in wild-type and Brdt knockout germ cells at 17 and 20 dpp during the first wave of spermatogenesis before the onset of overt phenotype in the Brdt mutants. This analysis clearly revealed that Brdt is a critical transcriptional activator of genes specific to meiotic and post-meiotic germ cells. By ChIP-seq. analysis, the authors showed that the genes affected by the Brdt knockout are bound by Brdt and are marked by acetylated histones. Furthermore, among many genes regulated by Brdt, the authors identified Ccna1 as a gene whose down-regulation well explain the phenotype of Brdt knockout germ cells. The authors provided evidence for the mechanism of action of Brdt as a transcriptional activator and for the action of Brdt in the replacement of hyperacetylated histones in elongating spermatids. This is a very nice piece of work with thorough analysis and is suitable for publication in EMBO Journal. I only have minor comments. Figure 1C , to show the expression of Brdt during adult spermatogenesis, it may be better to show the whole cross sections of seminiferous tubules with associated stages. Figure 2C , would it be possible to show quantification that meiotic progression is indeed normal until the pachytene stage in Brdt knockout germ cells by quantifying the number/ratio of leptotene, zygotene, and pachytene cells in wild-type and Brdt knockout germ cells?
Regarding the data shown in

1st Editorial Decision 26 July 2012
We have now received the final referee report, which you will find enclosed below. As is apparent, also reviewer #1 is in general supportive of publication in The EMBO Journal. Nevertheless, s/he raises some additional concerns, especially regarding the proposed book-marking function of Brdt, which should be appropriately addressed. Given the comments provided, I would like to invite you to submit a suitably revised manuscript to The EMBO Journal. I should add that it is our policy to allow only a single major round of revision and that it is therefore important to address the raised concerns at this stage.
When preparing your letter of response to the referees' comments, please bear in mind that this will form part of the Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process, please visit our website: http://www.nature.com/emboj/about/process.html Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely,
Editor
The EMBO Journal
Review of EMBOJ-2012-82354 Spermatogenesis is an essential process and is exceedingly interesting with regard to gene expression and chromatin regulation, however, mechanisms that modulate the dramatic chromatin changes are poorly understood. This study from the Khochbin lab is novel and important because the authors characterize the function of Brdt in mouse spermatogenesis for the first time. The BET family of bromodomain proteins are of high interest since they appear to be important in gene regulation and in epigenetic memory through the cell cycle, and are promising pharmaceutical targets. Here the authors show convincing and significant genome-wide transcriptional and ChIPseq data, indicating a gene regulatory function of Brdt for meiotic and post-meiotic genes. These data correspond nicely with sperm meiotic arrest phenotype of the homozygous Brdt knockout mouse. Thus, the author's argument that Brdt is a major determinant in the establishment of a testis-specific expression program is well supported.
The argument that Brdt provides a bookmarking function via binding to histone acetylation is interesting but several important questions should be addressed:
1. How was the purity of the cell fractions, meiotic and post-meiotic assessed? This is especially important as the authors are trying to make the case later that Brdt is "bookmarking" post-meiotic genes. What if there are post-meiotic cells contaminating the meiotic fraction, enough to affect the results?
For Fig4
, what specific histone acetylation is assayed? Are these Brdt-specific PTMs? It doesn't seem that the level of acetylation changes appreciably between meiosis and post-meiosis at these genes, so how does Brdt binding increase at some of the post-meiosis genes? Most importantly, it is important to show the histone acetylation ChIP in Brdt -/-.
3. The authors focus on de-regulation of the Ccna1 gene in Brdt-/-mice, and suggest that this deregulation may be the cause of meiotic arrest, however, they show that Brdt is not bound to this gene. Since the claim that Brdt is a master regulator of the meiotic transcriptional program via its bookmarking function is central to the study, it is important to discuss examples of genes that are directly regulated by Brdt and could account for the meiotic arrest.
4. They argue that Brdt is a tissue-specific Brd4 in that it "bookmarks" genes before meiosis and then recruits P-TEFb. The evidence for interaction with P-TEFb is the CoIP in Fig5a. This experiment needs additional controls to be convincing: -They are pulling down with antibodies against P-TEFb components Cdk9 and CyclinT1. Instead of using an IgG control pulldown, they do the IP in Brdt-/-mouse testes. This is not really a valid control, because there will not be pull down of any Brdt in Brdt-/-testes. Thus, this does not assess Brdt background binding. A much better background control would be IgG IP.
-The WB of Brdt in Fig1 looks clean, whereas the WB in Fig5 has many background bands that it is difficult to determine which is Brdt.
-Very important is the reciprocal IP, to pull down Brdt and blot for P-TEFb.
-Most convincing would be ChIP for P-TEFb in WT and Brdt-/-meiotic and post-meiotic cells at the Brdt-regulated genes, with the prediction that P-TEFb would be reduced in Brdt-/-cells. The phenotype with the C-terminally tagged Brdt is interesting, however the mechanism is not at all clear. It was not obvious why this would increase PTEFb binding, but show decreased binding for histone acetyl interaction. To back up this claim (co-IPs from HeLa/COS cells) it would be helpful to have IF of the tubules from the mice to visualize where Brdt and P-TEFb. The last part of the study claims that Brdt's BD1 is essential to link histone removal to transition proteins assembly. There are two problems here: first, they showed earlier that a lot of the genes that are de-regulated in Brdt-/-are also de-regulated in Brdt BD1∆. Thus, the phenotypes seen in postmeiotic cells in BD1∆ mice might be due to the de-regulation of the meiotic transcriptional program. Second, Brdt BD1∆ is mostly cytosolic and is not nuclear localized. The argument is not convincing that Brdt BD1∆ is cytosolic because it plays a role in the replacement of histones by transition proteins, for example it might be lacking its nuclear localization signal. In other words, if it could get into the nucleus, maybe it would still be able to remove acetylated histones without BD1.
Additional correspondence (editor) (Author correspondence not included) 27 July 2012
Although we would of course value a more detailed analysis of the mechanism of Brdt function, especially since the experiments are feasible for you, we do appreciate your concerns. Therefore, we would be willing to consider a swift revision that lacks the additional ChIP-Seq data requested by reviewer #2. Nevertheless, we would like to ask you to answer to the suggestions of reviewer #3, to add a more detailed description of the Brdt ChIP-Seq data as requested by reviewer #2 and to strengthen your co-IP data by including an IgG control as well as a reciprocal IP as suggested by reviewer #1. These revisions should be feasible in a short time frame of about two weeks. In order to address additional concerns raised by the reviewers, you might also want to consider toning down conclusions, if you deem it necessary. From our side, we can certainly promise efficient processing of the revised version of your manuscript. I would also like to bring to your attention that -as a general policy -we suggest authors to provide source data for all relevant Figures, e.g. not processed and uncut images of Western Blots, which can be time-consuming to retrieve.
Please do not hesitate to contact me if any of these points need further clarification or discussion.
Editor
The EMBO Journal 1st Revision -authors' response 07 August 2012
Once more, we would like to sincerely thank you for your appreciable help in managing the evaluation of our manuscript.
We have now taken into account all the points you raised in your mail of July 27th, as well as most of the referees' remarks, and accordingly revised the manuscript.
Regarding your points:
-The suggestions of reviewer N°3 are now taken into account (see also our reply to this referee), as follows: X-gal staining was performed on testis cryo-sections to precisely show the cell stages when Brdt promoter drives a lacZ expression. This is now shown in supplementary Figure S1 .
Histological sections of developing and adult testes from wild type Brdt+/+ or Brdt+/-and Brdt-/-illustrate that seminiferous tubules of various stages of the mice of these genotypes present comparable proportions of meiotic cells up to the diplotene stage. In addition, spermatocytes were counted in adult testis sections from Brdt-/-and Brdt+/+ mice and the results obtained confirm that, as previously mentioned in the text, up to the end of the meiotic I prophase, the number of spermatocytes are identical between the two genotypes. These data are now shown in supplementary Figure S2 .
-A description of the Brdt ChIP-Seq data and analysis parameters have now been added in supplementary Figure S3 and legend.
-We have now repeated the co-IP experiments three additional times and a non-relevant control IgG antibody was included each time. A figure was chosen as the new Figure 5A and a figure corresponding to one of the new experiments, plus the ex- Figure 5A , are now shown in the Supplementary Figure S4 . It is however of note that a reciprocal IP is not feasible since our anti-Brdt antibody is directed against a C-terminal peptide, which precisely corresponds to the binding site of P-TEFb complex. However, we believe that this problem is largely overcome by the fact that we could IP Brdt using two independent antibodies directed against the two components of P-TEFb: Cyclin T1 and Cdk9. The fact that two antibodies directed against two subunits of P-TEFb clearly coimmupoprecipitate Brdt, in addition to the control data from KO mice and the Ig control experiments, now strongly supports the existence of a "Brdt-P-TEFb" complex in spermatogenic cells.
-All the ChIP experiments requested by referees N°1 and N°2 would have indeed contributed to strengthen our bookmarking hypothesis. According to your suggestion, we have now toned down our statements about bookmarking, in the abstract as well as throughout the text. The bookmarking is now discussed only as a possibility in the discussion section. Additionally, as you will see in our reply to the reviewers, considering publically available ChIP-Seq data on Brd4 (one of the somatic type Brdt paralogs) and P-TEFb, we are not sure that the requested ChIP-Seq would have further strengthened our hypothesis. Indeed, although the Brd4-P-TEFb complex has been very well characterized by several groups, their ChIP-Seq peaks overlap on the genome is poor. Therefore if one seeks to take the genomic distributions of Brd4 and P-TEFb as a proof of the complex formation, the results might not support such a conclusion. Uncut images of all the Western Blots are provided as requested.
We have also prepared a detailed point-by-point reply to the referees' remarks, which follows Referee #1
How was the purity of the cell fractions, meiotic and post-meiotic assessed? This is especially important as the authors are trying to make the case later that Brdt is "bookmarking" post-meiotic genes. What if there are post-meiotic cells contaminating the meiotic fraction, enough to affect the results?
First of all, we have now toned down our bookmarking hypothesis throughout the text. Our transcriptomic analyses were performed on developing testes taken at the age of 20 dpp. At this age, there are almost no post-meiotic cells. Therefore a contamination could not be considered. The stage-specific expression profile of our lists of Brdt-dependent genes is clearly explained in the text (top of page 7). Regarding the experiments on fractionated spermatogenic cells, after every fractionation we control the purity by counting in each cell fraction spermatocytes and round spermatids, which are cells of different aspects and are easily identifiable. In the case of ChIP-Seq, we do not carry on the experiments if the contaminations are estimated to be above 5%.
For Fig4, what specific histone acetylation is assayed? Are these Brdt-specific PTMs?
Here, general histone acetylation was considered. Indeed, we reasoned that if we used antibodies against Brdt-specific acetylation sites, we could miss nucleosomes bound by Brdt due to the masking of the sites by Brdt bromodomains.
It doesn't seem that the level of acetylation changes appreciably between meiosis and post-meiosis at these genes, so how does Brdt binding increase at some of the post-meiosis genes?
We have now evidence that some other histone PTMs could modulate Brdt binding (unpublished), therefore it is possible to speculate that new histone PTMs could control Brdt release in the presence of acetylation. However, this will not be developed here since this point is beyond the scope of the present paper.
Most importantly, it is important to show the histone acetylation ChIP in Brdt -/-.
This is indeed an interesting question, which requires additional ChIP-Seqs. Along these lines it would also be interesting to complete these investigations by doing the same anti-acetyl histone ChIP-Seq in spermatogenic cells expressing delta BD1 Brdt. A Brdt ChIP-Seq in these cells should also be carried out to evaluate the role of Brdt's first bromodomain in Brdt binding and histone acetylation. In fact, we fully agree that this work raises many additional questions, but answering them would take us far beyond the present manuscript, which already dissects many new properties of Brdt.
The authors focus on de-regulation of the Ccna1 gene in Brdt-/-mice, and suggest that this deregulation may be the cause of meiotic arrest, however, they show that Brdt is not bound to this gene. Since the claim that Brdt is a master regulator of the meiotic transcriptional program via its bookmarking function is central to the study, it is important to discuss examples of genes that are directly regulated by Brdt and could account for the meiotic arrest.
Following this referee's suggestion, we have established a list of transcription factorencoding genes whose expression in spermatocytes requires the presence of Brdt. Among them, we selected those bound by Brdt at their TSS as direct targets of Brdt and good candidates for relaying indirect gene activations. 72 genes encoding known and unknown potentially transcriptional regulators (according to GO terms) were identified. Among them, 29 showed a Brdt peak at their TSS (not shown). However, these 29 genes are not well studied and there are no data to support a discussion on their role as a relay in gene expression or activation in spermatogenic cells. In order to avoid too much speculation, we decided not to further develop this point in the discussion section.
They argue that Brdt is a tissue-specific Brd4 in that it "bookmarks" genes before meiosis and then recruits P-TEFb. The evidence for interaction with P-TEFb is the CoIP in Fig5a. This experiment needs additional controls to be convincing: -They are pulling down with antibodies against P-TEFb components Cdk9 and CyclinT1. Instead of using an IgG control pulldown, they do the IP in Brdt-/-mouse testes. This is not really a valid control, because there will not be pull down of any Brdt in Brdt-/-testes. Thus, this does not assess Brdt background binding. A much better background control would be IgG IP.
The experiment was repeated and this time we also included the requested control antibody. This is shown in Figure 5A and explained in text (page 10, before the last paragraph). We have also repeated this experiment two additional times, and the results of one of the experiments along with the ex- Figure 5A are now presented in supplementary Figure S4 .
-The WB of Brdt in Fig1 looks clean, whereas the WB in Fig5 has many background bands that it is difficult to determine which is Brdt.
It appears to us that the Brdt band is clearly visible. This is the most intense band, which is absent in extracts from Brdt KO testes. The referee should note that, in order to detect Brdt after Cdk9 and CyclinT1 immunoprecipitation, taking into account that only a fraction of Brdt should be in a soluble complex, we reasoned that highly concentrated extracts should be used. This is why the background of the western is increased (ex- Figure 5A , now supplementary Figure S4B ). We also reasoned that the presence of extracts from Brdt KO testes would allow us to easily distinguish between Brdt and irrelevant bands which might be due to high protein concentration.
When we repeated this experiment with only wild type testis extracts, we changed the conditions and used a less concentrated extracts to see if we could improve this background issue. This has been performed twice. As can be seen now in Figure 5A and supplementary Figure S4A , IP continues to work well and the background signal is highly reduced. Under these new conditions, it is however more difficult to see Cdk9 in the input.
Unfortunately, we cannot perform this experiment because our immunoprecipitating antiBrdt antibody is directed against its C-ter domain, exactly where P-TEFb is bound. However, we are sure that the referee agrees that this problem is largely compensated by the fact that we succeeded in showing the Brdt-P-TEFb complex in spermatogenic cells by using two independent antibodies against the two components of P-TEFb complex: CyclinT1 and Cdk9. We should also point out that this masking effect does not seem to be a problem in ChIP-Seq, since upon chromatin binding, pTEB-b seems to dissociate and transferred to other sites (see below for more indications).
-Most convincing would be ChIP for P-TEFb in WT and Brdt-/-meiotic and postmeiotic cells at the Brdt-regulated genes, with the prediction that P-TEFb would be reduced in Brdt-/-cells.
We agree with the referee, but the need for a rapid processing of our manuscript is not compatible with the setting up of these experiments, which would require to be performed at large scale to be conclusive (see below). An additional point is that a close look at publically available ChIP-Seq data including anti-Brd4 and anti-P-TEFb antibodies published by Nicodeme et al. (Nature, pmid : 21068722) , shows that, in many cases, Brd4 and P-TEFb peaks are not overlapping, while it is now clearly established that Brd4 and P-TEFb are in a complex in the nucleosol.
The phenotype with the C-terminally tagged Brdt is interesting, however the mechanism is not at all clear. It was not obvious why this would increase PTEFb binding, but show decreased binding for histone acetyl interaction. To back up this claim (co-IPs from HeLa/COS cells) it would be helpful to have IF of the tubules from the mice to visualize where Brdt and P-TEFb.
P-TEFb is a nuclear factor and our IFs show a homogenous nuclear labelling in spermatogenic cell populations (not shown), therefore no clear conclusions could be drawn from this experiment. To address the question raised, we discuss in the text that the absence of recruitment of tagged-Brdt to chromatin could be a good reason to increase the pool of nucleosolic complex (hence the observed increase in P-TEFb binding), because of the inability of P-TEFb to be transferred to polII, which should normally occur after Brdt recruitment. The referee is absolutely right. We also mention this possibility in the discussion (page 17, bottom and page 18 top), but there is no simple way to tackle the issue. We are however convinced that it would be important to show the property of Brdt in vitro and in germ cells and discuss a possible working model. The cytoplasmic Brdt delta-BD1 appears when TPs are synthetized, since before that stage, Brdt delta-BD1 is seen in the nucleus of the cells. We have now added a new figure to show this phenomenon (supplementary Figure S9A) , where it can be seen that, in round spermatids, Brdt is nuclear in both genotypes (WT and deltaBD1). However, Brdt delta BD1 becomes trapped in the cytoplasm of deltaBD1 elongating spermatids at the time of TP synthesis (Fig. 7) , while the wild-type Brdt remains nuclear in these cells. The requested information about the ChIP-Seq data is now presented in the supplementary Figure S3 and its corresponding legend. We agree with the referee that ChIP-Seq showing P-TEFb genomic site occupation would increase the interest of this work. However, due to the necessity of a rapid processing of the manuscript, it is not possible to include these experiments in the revised version. Additionally, we had a close look at available ChIP-Seq data on Brdt paralog, Brd4, and P-TEFb (data published by Nicodeme and colleagues, Nature, pmid: 21068722), where a Brd4 and P-TEFb peaks overlap is not observed on many sites. ChIP-Seq using anti-H4K5ac would have also been interesting, but again we are not sure that we would have seen co-localizations with Brdt because of the masking of the H4K5ac by the Brdt bromodomain 1. Figure 1C , to show the expression of Brdt during adult spermatogenesis, it may be better to show the whole cross sections of seminiferous tubules with associated stages.
Second
2). The authors show that BRDT interacts with
Referee #3
Regarding the data shown in
We have now performed the staining on seminiferous tubule cryo-sections as requested. This is now shown as supplementary Figure S1 . Figure 2C, Figure S2 . To complete this part, we have also included in this Figure, representative sections of adult and developing testes corresponding to different genotypes. We confirm that the progression in spermatogenic differentiation is indeed normal until the end of diplotene stage. This conclusion is also supported by q-RT-PCR measurement of H1t mRNA, known to be expressed in pachytene cells, which shows a comparable expression in Brdt wild type and Brdt KO testes until 20 dpp ( Figure 5B ).
